Emergent BioSolutions(EBS) Stock Price Today

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US Stock MarketDetailed Quotes

EBS Emergent BioSolutions

Watchlist

5.840
+0.150+2.64%

Close Mar 19 16:00 ET

5.840
0.0000.00%

Post 20:01 ET

317.33MMarket Cap-1.62P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Press Release: Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International
Dow Jones16:30 ET
Express News | Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International
Reuters16:30 ET
Emergent BioSolutions Announces $27M in Incremental Sales
TipRanksMar 18 08:20 ET
Express News | Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers With Five Critical Medical Countermeasure Products
ReutersMar 18 08:00 ET
The tariff war between the US and Europe is escalating, and Trump's 'tariff big stick' is making the pharmaceutical industry tremble.
Pharmaceutical companies are urging the Trump administration and EU officials to exclude Medical products from the escalation of the trade war.
Zhitong FinanceMar 18 03:00 ET
VISIT FLORIDA and Emergent Media Partner on Two Creator-Led Original Video Series
PR NewswireMar 17 11:00 ET

Comments

Jaguar8

7 hours ago

NEWS

$Emergent BioSolutions (EBS.US)$
Emergent BioSolutions Finalizes Sale of Baltimore-Bayview Manufacturing Site to Syngene International
Wednesday, 19th March at 4:30 pm
GAITHERSBURG, Md., March 19, 2025 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced that it has completed the sale of its Baltimore-Bayview drug substance manufacturing facility to Syngene International. Emergent received approximately $36.5 million at closing, which is subject to customary post-closing...

Trytosaveabit

Mar 18 20:01

Update

$Emergent BioSolutions (EBS.US)$ Reuters· just1min
Emergent BioSolutions Announces Approximately $27 Million in Incremental Sales to Supply International Customers With Five Critical Medical Countermeasure Products

Jaguar8

Mar 13 20:34

NEWS

$Emergent BioSolutions (EBS.US)$
to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs
Thursday, 13th March at 8:29 am
NYC Building & Construction Industry Safety Fund program will equip local workers, contractors and staff with NARCAN® Nasal Spray and provide trainings on how to administer the life-saving medicine
Leading mental health and addiction treatment services provider, Pathway Healthcare, breaks down stigma and access ...

Trytosaveabit

Mar 13 20:32

Hmm

$Emergent BioSolutions (EBS.US)$ Emergent BioSolutions Reinforces its Commitment to Expanding Access to NARCAN® Nasal Spray by Supporting Organizations with New Opioid Overdose Preparedness Programs
2 MINUTES AGO, 8:29 AM EDT
VIA GLOBENEWSWIRE
NYC Building & Construction Industry Safety Fund program will equip local workers, contractors and staff with NARCAN® Nasal Spray and provide trainings on how to administer the life-saving medicine
Leading mental health and addiction treatment services p...